4-Amino-1-oxyl-2,2,6,6-tetramethylpiperidine-3-carboxylic acid (β-TOAC), the first spin-labelled, cyclic, chiral β-amino acid resolved in an enantiomerically pure state

Tetrahedron Letters

Volumn 44, Issue 16, 2003, Pages 3381-3384

  Wright, Karen ^a   Crisma, Marco ^b   Toniolo, Claudio ^b   Török, Roland ^c   Péter, Antal ^c   Wakselman, Michel ^a   Mazaleyrat, Jean Paul ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Chiral nitroxides; Modified amino acids; Spin labelled amino acids

Indexed keywords

3 CARBOXYMETHYL 1 OXYL 2,2,6,6 TETRAMETHYL 4 PIPERIDONE; 4 AMINO 1 OXYL 2,2,6,6 TETRAMETHYLPIPERIDINE 3 CARBOXYLIC ACID; BETA AMINO ACID; CARBOXYLIC ACID DERIVATIVE; PIPERIDONE DERIVATIVE; UNCLASSIFIED DRUG;

AMINATION; ARTICLE; CHIRALITY; DIASTEREOISOMER; ENANTIOMER; SPIN LABELING;

EID: 0037436914     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(03)00572-0     Document Type: Article

References (50)

1. Griffith O.H., Waggoner A.S. Acc. Chem. Res. 2:1969;17-24.
2. Keana J.F. Chem. Rev. 78:1978;37-64.
3. Millhauser G.L. Trends Biochem. Sci. 17:1992;448-452.
4. Columbus L., Hubbell W.L. Trends Biochem. Sci. 27:2002;288-295.
5. Beckwith A.L.J., Bowry V.W., Ingold K.U. J. Am. Chem. Soc. 114:1992;4983-4992.
6. Bowry V.W., Ingold K.U. J. Am. Chem. Soc. 114:1992;4992-4996.
7. Hawker C.J., Bosman A.W., Harth E. Chem. Rev. 101:2001;3661-3688.
8. Berliner L.J., Khramtsov V., Fujii H., Clanton T.L. Free Radic. Biol. Med. 30:2001;489-499.
9. Adam W., Saha-Möller C.R., Ganeshpure P.A. Chem. Rev. 101:2001;3499-3548.
10. Sheldon R.A., Arends I.W.C.E., Ten Brink G.-J., Dijksman A. Acc. Chem. Res. 35:2002;774-781.
11. Arterburn J.S. Tetrahedron. 57:2001;9765-9768.
12. Naik N., Braslau R. Tetrahedron. 54:1998;667-696.
13. Formaggio F., Bonchio M., Crisma M., Peggion C., Mezzato S., Polese A., Barazza A., Antonello S., Maran F., Broxterman Q.B., Kaptein B., Kamphuis J., Vitale R.M., Saviano M., Benedetti E., Toniolo C. Chem. Eur. J. 8:2002;84-93.
14. Toniolo C., Formaggio F., Crisma M., Mazaleyrat J.-P., Wakselman M., George C., Deschamps J., Flippen-Anderson J.L., Pispisa B., Venanzi M., Palleschi A. Chem. Eur. J. 5:1999;2254-2264.
15. Corvaja C., Sartori E., Toffoletti A., Formaggio F., Crisma M., Toniolo C., Mazaleyrat J.P., Wakselman M. Chem. Eur. J. 6:2000;2775-2782.
16. Rassat A., Rey P. Bull. Soc. Chim. Fr. 3:1967;815-817.
17. Nakaie C.R., Goissis G., Schreier S., Paiva A.C.M. Braz. J. Med. Biol. Res. 14:1981;173-180.
18. Seidemann R., Dulog L. Makromol. Chem. 187:1986;2545-2551.
19. Toniolo C., Crisma M., Formaggio F. Biopolymers. 47:1998;153-158.
20. Marchetto R., Schreier S., Nakaie C.R. J. Am. Chem. Soc. 115:1993;11042-11043.
21. Toniolo C., Valente E., Formaggio F., Crisma M., Pilloni G., Corvaja C., Toffoletti A., Martinez G.V., Hanson M.P., Millhauser G.L., George C., Flippen-Anderson J.L. J. Peptide Sci. 1:1995;45-47.
22. Martin L., Ivancich A., Vita C., Formaggio F., Toniolo C. J. Peptide Res. 58:2001;424-432.
23. Tominaga M., Barbosa S.R., Poletti E.F., Zukerman-Schpector J., Marchetto R., Schreier S., Paiva A.C.M., Nakaie C.R. Chem. Pharm. Bull. 49:2001;1027-1029.
24. Nakaie C.R., Silva E.G., Cilli E.M., Marchetto R., Schreier S., Paiva T.B., Paiva A.C.M. Peptides. 23:2002;65-70.
25. We have recently achieved the resolution of POAC. See: Wright, K.; Formaggio, F.; Toniolo, C.; Török, R.; Péter, A.; Wakselman, M.; Mazaleyrat, J.-P., manuscript in preparation.
26. For review articles, see: (a) Koert, U. Angew. Chem., Int. Ed. Engl. 1997, 36, 1836-1387; (b) Iverson, B. L. Nature 1997, 385, 113-115; (c) Borman, S. Chem. Eng. News 1997, 32-35 (June 16); (d) Seebach, D.; Matthews, J. L. J. Chem. Soc., Chem. Commun. 1997, 2015-2022; (e) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173-180; (f) Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med. Chem. 1999, 6, 905-925; (g) Wu, Y.-D.; Wang, D.-P. J. Am. Chem. Soc. 1999, 121, 9352-9362; (h) Hartgerink, J. D.; Clark, T. D.; Ghadiri, M. R. Chem. Eur. J. 1998, 4, 1367-1372; (i) DeGrado, W. F.; Schneider, J. P.; Hamuro, Y. J. Peptide Res. 1999, 54, 206-217.
27. For review articles, see: (a) Koert, U. Angew. Chem., Int. Ed. Engl. 1997, 36, 1836-1387; (b) Iverson, B. L. Nature 1997, 385, 113-115; (c) Borman, S. Chem. Eng. News 1997, 32-35 (June 16); (d) Seebach, D.; Matthews, J. L. J. Chem. Soc., Chem. Commun. 1997, 2015-2022; (e) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173-180; (f) Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med. Chem. 1999, 6, 905-925; (g) Wu, Y.-D.; Wang, D.-P. J. Am. Chem. Soc. 1999, 121, 9352-9362; (h) Hartgerink, J. D.; Clark, T. D.; Ghadiri, M. R. Chem. Eur. J. 1998, 4, 1367-1372; (i) DeGrado, W. F.; Schneider, J. P.; Hamuro, Y. J. Peptide Res. 1999, 54, 206-217.
28. For review articles, see: (a) Koert, U. Angew. Chem., Int. Ed. Engl. 1997, 36, 1836-1387; (b) Iverson, B. L. Nature 1997, 385, 113-115; (c) Borman, S. Chem. Eng. News 1997, 32-35 (June 16); (d) Seebach, D.; Matthews, J. L. J. Chem. Soc., Chem. Commun. 1997, 2015-2022; (e) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173-180; (f) Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med. Chem. 1999, 6, 905-925; (g) Wu, Y.-D.; Wang, D.-P. J. Am. Chem. Soc. 1999, 121, 9352-9362; (h) Hartgerink, J. D.; Clark, T. D.; Ghadiri, M. R. Chem. Eur. J. 1998, 4, 1367-1372; (i) DeGrado, W. F.; Schneider, J. P.; Hamuro, Y. J. Peptide Res. 1999, 54, 206-217.
29. For review articles, see: (a) Koert, U. Angew. Chem., Int. Ed. Engl. 1997, 36, 1836-1387; (b) Iverson, B. L. Nature 1997, 385, 113-115; (c) Borman, S. Chem. Eng. News 1997, 32-35 (June 16); (d) Seebach, D.; Matthews, J. L. J. Chem. Soc., Chem. Commun. 1997, 2015-2022; (e) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173-180; (f) Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med. Chem. 1999, 6, 905-925; (g) Wu, Y.-D.; Wang, D.-P. J. Am. Chem. Soc. 1999, 121, 9352-9362; (h) Hartgerink, J. D.; Clark, T. D.; Ghadiri, M. R. Chem. Eur. J. 1998, 4, 1367-1372; (i) DeGrado, W. F.; Schneider, J. P.; Hamuro, Y. J. Peptide Res. 1999, 54, 206-217.
30. For review articles, see: (a) Koert, U. Angew. Chem., Int. Ed. Engl. 1997, 36, 1836-1387; (b) Iverson, B. L. Nature 1997, 385, 113-115; (c) Borman, S. Chem. Eng. News 1997, 32-35 (June 16); (d) Seebach, D.; Matthews, J. L. J. Chem. Soc., Chem. Commun. 1997, 2015-2022; (e) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173-180; (f) Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med. Chem. 1999, 6, 905-925; (g) Wu, Y.-D.; Wang, D.-P. J. Am. Chem. Soc. 1999, 121, 9352-9362; (h) Hartgerink, J. D.; Clark, T. D.; Ghadiri, M. R. Chem. Eur. J. 1998, 4, 1367-1372; (i) DeGrado, W. F.; Schneider, J. P.; Hamuro, Y. J. Peptide Res. 1999, 54, 206-217.
31. For review articles, see: (a) Koert, U. Angew. Chem., Int. Ed. Engl. 1997, 36, 1836-1387; (b) Iverson, B. L. Nature 1997, 385, 113-115; (c) Borman, S. Chem. Eng. News 1997, 32-35 (June 16); (d) Seebach, D.; Matthews, J. L. J. Chem. Soc., Chem. Commun. 1997, 2015-2022; (e) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173-180; (f) Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med. Chem. 1999, 6, 905-925; (g) Wu, Y.-D.; Wang, D.-P. J. Am. Chem. Soc. 1999, 121, 9352-9362; (h) Hartgerink, J. D.; Clark, T. D.; Ghadiri, M. R. Chem. Eur. J. 1998, 4, 1367-1372; (i) DeGrado, W. F.; Schneider, J. P.; Hamuro, Y. J. Peptide Res. 1999, 54, 206-217.
32. For review articles, see: (a) Koert, U. Angew. Chem., Int. Ed. Engl. 1997, 36, 1836-1387; (b) Iverson, B. L. Nature 1997, 385, 113-115; (c) Borman, S. Chem. Eng. News 1997, 32-35 (June 16); (d) Seebach, D.; Matthews, J. L. J. Chem. Soc., Chem. Commun. 1997, 2015-2022; (e) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173-180; (f) Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med. Chem. 1999, 6, 905-925; (g) Wu, Y.-D.; Wang, D.-P. J. Am. Chem. Soc. 1999, 121, 9352-9362; (h) Hartgerink, J. D.; Clark, T. D.; Ghadiri, M. R. Chem. Eur. J. 1998, 4, 1367-1372; (i) DeGrado, W. F.; Schneider, J. P.; Hamuro, Y. J. Peptide Res. 1999, 54, 206-217.
33. For review articles, see: (a) Koert, U. Angew. Chem., Int. Ed. Engl. 1997, 36, 1836-1387; (b) Iverson, B. L. Nature 1997, 385, 113-115; (c) Borman, S. Chem. Eng. News 1997, 32-35 (June 16); (d) Seebach, D.; Matthews, J. L. J. Chem. Soc., Chem. Commun. 1997, 2015-2022; (e) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173-180; (f) Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med. Chem. 1999, 6, 905-925; (g) Wu, Y.-D.; Wang, D.-P. J. Am. Chem. Soc. 1999, 121, 9352-9362; (h) Hartgerink, J. D.; Clark, T. D.; Ghadiri, M. R. Chem. Eur. J. 1998, 4, 1367-1372; (i) DeGrado, W. F.; Schneider, J. P.; Hamuro, Y. J. Peptide Res. 1999, 54, 206-217.
34. For review articles, see: (a) Koert, U. Angew. Chem., Int. Ed. Engl. 1997, 36, 1836-1387; (b) Iverson, B. L. Nature 1997, 385, 113-115; (c) Borman, S. Chem. Eng. News 1997, 32-35 (June 16); (d) Seebach, D.; Matthews, J. L. J. Chem. Soc., Chem. Commun. 1997, 2015-2022; (e) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173-180; (f) Gademann, K.; Hintermann, T.; Schreiber, J. V. Curr. Med. Chem. 1999, 6, 905-925; (g) Wu, Y.-D.; Wang, D.-P. J. Am. Chem. Soc. 1999, 121, 9352-9362; (h) Hartgerink, J. D.; Clark, T. D.; Ghadiri, M. R. Chem. Eur. J. 1998, 4, 1367-1372; (i) DeGrado, W. F.; Schneider, J. P.; Hamuro, Y. J. Peptide Res. 1999, 54, 206-217.
35. Lee H.-S., LePlae P.R., Porter E.A., Gellman S.H. J. Org. Chem. 66:2001;3597-3599.
36. LePlae P.R., Umezawa N., Lee H.-S., Gellman S.H. J. Org. Chem. 66:2001;5629-5632.
37. Xu D., Prasad K., Repic O., Blacklock T.J. Tetrahedron: Asymmetry. 8:1997;1445-1451.
38. Schinnerl M., Murray J.K., Langenhan J.M., Gellman S.H. Eur. J. Org. Chem. 2003;721-726.
39. Rauckman E.J., Rosen G.M., Abou-Donia M.B. Synth. Commun. 5:1975;409-413.
40. Mori H., Ohara M., Kwan T. Chem. Pharm. Bull. 28:1980;3178-3183.
41. 25 are as follows: (R)-3: -441 (c 0.25;MeOH). (S)-3: +456 (c 0.26; MeOH). (1′R,3S,4S)-4: +48 (c 0.25; MeOH). (1′R,3R,4R)-4: +41 (c 0.25; MeOH). (1′S,3R,4R)-4: -52 (c 0.26; MeOH). (1′S,3S,4S)-4: -47 (c 0.25; MeOH). (3S,4S)-5: +23 (c 0.1; MeOH). (3R,4R)-5: -22 (c 0.1; MeOH). (3S,4S)-6: -25 (c 0.1; MeOH). (3R,4R)-6: +23 (c 0.2; MeOH).
42. 13C NMR spectra of the nitroxide products in this study could only be obtained by preliminary use of the sodium dithionite reduction procedure proposed in Ref. 18.
43. Ozinskas A.J., Bobst A.M. Helv. Chim. Acta. 63:1980;1407-1411.
44. Rosen G.M. J. Med. Chem. 17:1974;358-360.
45. X-Ray quality crystals of (1′S,3R,4R)-4 were obtained by recrystallisation from acetonitrile solution. CCDC 204395 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge at http://www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: (internat.) +44-1223/336-033; E-mail: deposit@ccdc.cam.ac.uk].
46. Cimarelli C., Palmieri G. J. Org. Chem. 61:1996;5557-5563.
47. Rozantsev E.G. Free Nitroxyl Radicals. 1965;Plenum Press, New York.
48. Keana J.F.W., Norton R.S., Morello M., Van Engen D., Clardy J. J. Am. Chem. Soc. 100:1978;934-937.
49. Dulog L., Wang W. Liebigs Ann. Chem. 1992;301-303.
50. 6 (aq.): MeCN 70:30, flow rate 0.5 mL/min, detection 254 nm, column temperature 30°C.